Return to search results
Bendamustine hydrochloride
Bendamustine Hydrochloride is a generic prescription drug, available as an injectable powder in 25 mg and 100 mg vials, administered intravenously. It's an alkylating agent used to treat certain blood cancers like chronic lymphocytic leukemia and non-Hodgkin lymphoma. Manufactured by Accord Healthcare, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Bendamustine Hydrochloride is a generic prescription drug, available as an injectable powder in 25 mg and 100 mg vials, administered intravenously. It's an alkylating agent used to treat certain blood cancers like chronic lymphocytic leukemia and non-Hodgkin lymphoma. Manufactured by Accord Healthcare, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Bendamustine hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Bendamustine hydrochloride — ANDA 208194 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208194"
}
]
|
| identifier | ANDA208194 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"fda",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Bendamustine hydrochloride |
